Editorial endorsementChronicle Editorial Board · October 3, 2026
Prop 38 is one of the most noxious deposits on California’s political dung heap in years.
The Chronicle urges a No vote, citing the measure’s preferential $4.2 billion award to a new institute that lacks a track record, completed facilities, key leadership and a public strategic plan.
“They should spend their own money and come back to taxpayers when their institute actually has some progress to show.”
Read the Chronicle endorsement ↗Open letter · September 28, 2026
UC Regents urged to release the CIII–UCLA agreement before voters cast their ballots.
“Voters need and expect” the facts before deciding whether to borrow $8.4 billion.
The No on Proposition 38 campaign is asking the University of California to expedite release of the 80-page affiliation agreement governing UCLA’s relationship with the institute likely to receive $4.2 billion under Proposition 38.
The Sacramento BeeMcClatchy California Editorial Board
Editorial endorsement · September 30, 2026
“Proposition 38 is a sleeper on the ballot. California voters should beware.”
McClatchy’s California editorial board urges voters to look closely at an $8.4 billion borrowing proposal that would direct half its proceeds to a single UC-affiliated institute.
Read the editorial endorsement ↗San Diego Union-TribuneOpinion
Robert M. Kaplan · October 1, 2026
Proposition 38 promises far more than it can deliver.
Biomedical researcher and former NIH associate director Robert M. Kaplan explains why uncertain discoveries and royalty revenue cannot be treated as a dependable plan for repaying billions in taxpayer-backed debt.
Read Kaplan’s opinion article ↗Courage California · Endorsement · September 23, 2026
Courage California announces opposition to Proposition 38.
“Courage California urges voters to reject Proposition 38 as another naked attempt by billionaires to exploit taxpayer dollars for their own gain.”—Irene Kao, Executive Director, Courage California
The statewide organization’s statement says California has many leading immunology research institutions and calls for research funding to be distributed more equitably and transparently.
San Diego Union-Tribune · Editorial endorsement · September 18, 2026
“An $8.4 billion wolf in sheep’s clothing”
The San Diego Union-Tribune endorses a No vote on Proposition 38. Read the editorial board’s case against the measure.
Read the endorsement ↗Los Angeles TimesCapitol Journal
George Skelton · September 21, 2026
Why Proposition 38 should make California voters skeptical.
In his review of California’s November bond measures, veteran Capitol columnist George Skelton calls Proposition 38 “problematic” and focuses on its apparent benefit to a single UCLA-affiliated institute co-founded and led by its chief backer.
“Being backed by a billionaire isn’t the problem. It’s being written to substantially benefit one research institute that’s led by the billionaire.”—George Skelton, Los Angeles Times
Read the Los Angeles Times column ↗Golden State ReportCommentary
Paul Thornton · September 21, 2026
Prop. 38 is an unethical way to fund lifesaving medical research.
Thornton supports the promise of immunotherapy, but argues that Proposition 38 abandons open, competitive scientific grantmaking while positioning one not-yet-open institute to receive more than $4 billion.
“Knowing that my wife and late mother might have benefitted from a similar bond, I will still vote against it.”—Paul Thornton, Golden State Report
Read the Golden State Report article ↗POZHIV/AIDS community perspective
California’s Prop 38 immunotherapy bond promises almost nothing for HIV/AIDS.
An HIV/AIDS activist examines the gap between the measure’s broad promises and its actual funding requirements. Proposition 38 specifically reserves at least $4.2 billion for cancer, heart disease and Alzheimer’s research, while providing no dedicated allocation for HIV/AIDS research.
A community perspective on who is—and is not—assured funding under Proposition 38.
Read the article at POZ ↗San Francisco Chronicle Open Forum · September 12, 2026
Two cancer survivors agree: Prop 38 is the wrong way to fund medical research.
By Jon Fleischman and Steve Maviglio
“The debt is guaranteed. The discoveries and royalties are not.”
A conservative and a Democrat explain why their personal commitment to finding better cancer treatments leads them to oppose Proposition 38’s unfair financing scheme.
Read the op-ed →The Sacramento Bee · September 11, 2026
Retired analysts raise transparency concerns over Prop 38.
The Bee reports on concerns raised by former Legislative Analyst’s Office experts about Proposition 38’s funding structure, accountability provisions and apparent benefit to one institution.
Supporting scientific research does not require supporting Proposition 38.Judy Heiman’s takeaway
Read the Sacramento Bee story ↗
▶Watch the press conferenceCampaign video · September 10, 2026
Press conference with former LAO analysts.
Campaign policy experts explain their opposition to Proposition 38 and answer questions about the measure’s funding structure, public debt and lack of open competition.
Watch the press conference →CalMatters · July 31, 2026 · Updated August 3, 2026
This CA proposition will send $4 billion to a single nonprofit. Who’s behind it?
CalMatters examines Proposition 38’s eligibility requirements and reports that they very likely point to a single UCLA-affiliated institute—without naming it for voters in the measure.
Read the CalMatters reporting ↗CalMatters · Video explainer
Prop 38 explained.
CalMatters presents both sides of Proposition 38 and explains how the $8.4 billion bond would distribute research funding.
What the video makes clear: Half the money—$4.2 billion—would go to one unnamed institute selected under highly specific eligibility rules.
Watch on YouTube ↗Science · Independent reporting
California to vote on spending $16 billion to boost research after Trump cuts
Science examines Proposition 38’s unusual funding structure and reports on concerns raised by Dr. Robert Kaplan and David Panush about directing half the bond money to a single institution outside a competitive, peer-reviewed process.
“There is a strong case for investing more in biomedical research, but Proposition 38 is not the right way to do it.”—Dr. Robert Kaplan
Read the Science article ↗
▶Watch the KCRA 3 reportKCRA 3 · Video report · August 30, 2026
California voters weigh the promises—and the price—of Proposition 38.
KCRA presents both sides of the measure and explains that roughly $4 billion would go to one unnamed institute, while taxpayers would repay an estimated $12.5 billion from the General Fund. Any research revenue that might offset those costs is not guaranteed.
“Bonds sound really good. They sound like free money, but they’re not free money.”—Susan Shelley, Howard Jarvis Taxpayers Association
Watch at KCRA 3 ↗Ballot recommendation · League of Women Voters of California
League of Women Voters of California recommends No on Proposition 38.
The League says the measure would commit taxpayers to decades of debt while restricting California’s future research choices.
Read the League’s analysis ↗Editorial endorsement · Orange County Register · August 23, 2026
Orange County Register endorses No on Proposition 38.
Calls Prop 38 “an $8.4 billion money grab.”
Read the endorsement ↗Campaign statement · Open letter
An Open Letter to Prop 38 Proponents
No on Proposition 38 asks the measure’s proponents to explain why more than $4 billion appears reserved for a single institution—and why ordinary safeguards of competition, peer review and full public transparency do not appear to apply.
Read the open letter →Press Release #1 · August 3, 2026 · PDF
CalMatters investigation reveals Prop 38 would steer $4.2 billion to its top donor’s institution
The No on Proposition 38 campaign responds to the investigation and calls for open competition, full transparency and honest accounting for billions in taxpayer-backed debt.
Read Press Release #1 →Campaign fact sheet · September 12, 2026
Prop 38 Says It Will Pay for Itself. California Has Heard That Before.
California’s stem-cell bonds show why promised research royalties should not be confused with guaranteed repayment of billions in public debt.
Read the fact sheet →Independent voter guide · Pete Rates the Propositions
Pete Stahl rates Proposition 38: No.
Stahl has published plain-language recommendations for nearly every California statewide election since 1980. He calls Proposition 38 a misuse of both bond financing and the initiative process.
“Government funding should be distributed competitively, based on the merit of the applicants, not who wrote the proposition.”
Read Pete’s Proposition 38 rating ↗Additional coverage · Orange County Register · July 2, 2026
What is Proposition 38 before California voters in the 2026 election?
Read at the Orange County Register ↗Additional coverage · California Globe · August 4, 2026
Proposition 38 Benefits Its Billionaire Backers
Read at the California Globe ↗Additional coverage · Times of San Diego · September 7, 2026
Voters could fund what Trump and California lawmakers will not
“A ‘No’ vote does not reject science. It rejects an inefficient financing mechanism and a fragmented approach to setting research priorities.”—Robert M. Kaplan
Read at Times of San Diego ↗